NIH Common FundThe NIH Common Fund has received additional funds through the American Recovery & Reinvestment Act of 2009 (Recovery Act; Pub. L. No. 111-5) and is supporting several new funding opportunities. NIH Roadmap program areas will be among the priority areas for the ARRA Common Funds. More about the NIH Common Fund... About the NIH RoadmapThe NIH Roadmap for Medical Research was launched in September, 2004, to address roadblocks to research and to transform the way biomedical research is conducted by overcoming specific hurdles or filling defined knowledge gaps. Roadmap programs span all areas of health and disease research and boundaries of NIH Institutes and Centers (ICs). These are programs that might not otherwise be supported by the NIH ICs because of their scope or because they are inherently risky. Roadmap Programs are expected to have exceptionally high potential to transform the manner in which biomedical research is conducted. They are also expected to be short term, 5–10 year programs. This incubator space time frame is intended to allow the major roadblocks that were defined for each program to be overcome, thereby stimulating further research conducted through the ICs. Roadmap programs were initially funded by a 1 percent contribution from each of the NIH ICs. In 2006, Congress responded to the need for NIH to develop innovative and cross-cutting programs by authorizing and funding the NIH Common Fund within the Office of the Director. The annual Common Fund budget was $498 million in 2008, highlighting its importance in the overall NIH funding environment. To date, the Common Fund has been used exclusively to support the Roadmap. Scientific AreasPlanning and implementation of Roadmap/Common Fund programs are highly dynamic to allow the NIH the flexibility to respond quickly to new ideas, challenges, gaps and advances in biomedicine. Roadmap/Common Fund programs are developed from a strategic planning process involving broad, representative input from multiple scientific and public sources. Through this process, 12 roadblocks were articulated that are being addressed through many initiatives. These 12 challenges have been categorized according to three themes: New Pathways to Discovery, Research Teams of the Future, and Reengineering the Clinical Research Enterprise. Initiatives funded through the Roadmap/Common Fund fit into one or more of these major themes and address specific roadblocks or gaps to:
Although the NIH Roadmap is still in its infancy, many of its programs have achieved significant research advances. |
News & Events |
This page last reviewed: April 17, 2009